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Abstract
Understanding the phenotypic development of human induced pluripotent stem cell-derived 
cardiomyocytes (hiPSC-CMs) is a prerequisite to advancing regenerative cardiac therapy, disease 
modeling, and drug screening applications. Lack of consistent hiPSC-CM in vitro data can be 
largely attributed to the inability of conventional culture methods to mimic the structural, 
biochemical, and mechanical aspects of the myocardial niche accurately. Here, we present a 
nanogrid culture array comprised of nanogrooved topographies, with groove widths ranging from 
350 to 2000 nm, to study the effect of different nanoscale structures on the structural development 
of hiPSC-CMs in vitro. Nanotopographies were designed to have a biomimetic interface, based on 
observations of the oriented myocardial extracellular matrix (ECM) fibers found in vivo. 
Nanotopographic substrates were integrated with a self-assembling chimeric peptide containing 
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the Arg-Gly-Asp (RGD) cell adhesion motif. Using this platform, cell adhesion to peptide-coated 
substrates was found to be comparable to that of conventional fibronectin-coated surfaces. 
Cardiomyocyte organization and structural development were found to be dependent on the 
nanotopographical feature size in a biphasic manner, with improved development achieved on 
grooves in the 700–1000 nm range. These findings highlight the capability of surface-
functionalized, bioinspired substrates to influence cardiomyocyte development, and the capacity 
for such platforms to serve as a versatile assay for investigating the role of topographical guidance 
cues on cell behavior. Such substrates could potentially create more physiologically relevant in 
vitro cardiac tissues for future drug screening and disease modeling studies.
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1. INTRODUCTION
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold great 
potential for the development of physiologically relevant in vitro models of myocardial 
tissue for improving preclinical drug screening, disease modeling, and mechanistic studies 
of cardiac development.1–4 However, a technical limitation in the application of these 
hiPSC-derived cardiac cultures is that the cardiomyocytes are phenotypically immature 
compared to those present in the adult heart.5 Immature structural, metabolic, and/or 
functional phenotypes reduce the effectiveness of stem cell-derived cardiac technologies 
because the engineered tissue is a poor representation of the mature myocardium.6 
Therefore, improved maturation of hiPSC-CMs in vitro toward more adultlike phenotypes is 
crucial for the advancement of the field.
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To address this issue, bioengineers have investigated the integration of hiPSC-CMs with 
numerous techniques for recreating single or multiple characteristics of the native cardiac 
niche in vitro.7–10 The structure of the heart is organized on multiple scales to help promote 
effective blood ejection from the ventricles and direct the collective movement of action 
potentials along the tissue to provide strong synchronous contractions.11 Tissue alignment is 
apparent on all levels, from the three-dimensional ultrastructure of the cardiac tissue down to 
micron-scale sarcomeres within individual cells.12,13 To induce similar physiological 
cellular organization in vitro, we can use topographic cues to manipulate such responses.14 
This is illustrated by visible and consistent cellular alignment along a common axis and 
morphological elongation in a manner that is conducive to cellular processes such as 
migration and differentiation.15,16 Furthermore, different types of topographies, such as 
aligned grooves and pillars, have been used to regulate cell morphology and the 
development of anisotropic conduction patterns.17–19 In the case of cardiac muscle, it has 
been shown that an underlying nanoscale topography which mimics the dimensions and 
orientation of the cardiac extracellular matrix (ECM) is capable of promoting the anisotropic 
orientation of cultured rodent cardiomyocytes.15 The use of biomimetic topographies 
capable of orienting cells in this manner helps drive the development of cellular structure 
and function in engineered cardiac tissues.15,20 However, optimal dimensions for nanoscale 
topographies in terms of promoting stem cell derived cardiomyocyte development have yet 
to be established. Furthermore, the capacity for human-derived cardiac cells to respond to 
exogenous structural cues in a manner similar to that observed in rodent cells has yet to be 
demonstrated.
In addition to exogenous mechanical cues, ECM signaling is known to be a potent regulator 
of cellular activity, stimulating or inhibiting pathways that promote proliferation, migration, 
and/or differentiation.21–23 Cellular adhesion to the ECM is largely mediated by a family of 
membrane-bound proteins named integrins.24 Commonly expressed within fibers of the 
ECM is a three peptide sequence, Arg-Gly-Asp (RGD), that is well-known for its ability to 
promote integrin-mediated cellular adhesion.25 In the case of the myocardium, RGD is 
found in repeating segments of fibronectin, which facilitates cell-matrix binding through the 
activity of the α5β1 integrin complex.26
Biopolymers, such as fibronectin, laminin, and collagen,27 are often used to coat culture 
surfaces in order to improve cellular adhesion and development, and such methods have 
been shown to offer a reliable means of ensuring cell attachment. However, the cost of 
isolating and purifying human polymers, such as fibronectin, is extremely expensive. 
Synthetic polymers offer a cost-effective alternative to natural biopolymers, but those used 
for nanofabrication are often limited by their lack of physiological properties in biological 
settings, which provides a less than ideal environment for cell culture. In order to address 
this issue, many laboratories functionalize polymers with biological motifs that facilitate a 
cell-friendly environment. In such cases, 1-ethyl-3-(3 dimethylaminopropyl)-carbodiimide 
(EDC) chemistry is often used to covalently link polymeric and biological molecules 
together.28 Although previous groups have demonstrated some success in binding 
biologically relevant peptides or proteins to synthetic polymers,29–31 the process is limited 
by chemical cross-linking reagents and suboptimal reaction environments. In addition, 
conjugation chemistry results in poor yields, and does not provide strict control over surface 
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distribution of the biological molecule. This lack of definition in the culture substrate, in 
terms of thickness of the deposition layer, variable coverage, and nonuniform presentation of 
cell binding antigens, introduces a level of variability into culture surfaces prepared with 
these peptides. The development of a fully defined culture substrate, with uniform 
presentation of cell binding motifs, would therefore be beneficial to investigators seeking to 
generate more reproducible and cost-effective culture environments for subsequent cell 
culture studies.
Over the past decade, solid binding peptides have been utilized increasingly as biomolecular 
surface functionalization agents due to their selectivity and high affinity to the materials. 
These peptides have demonstrated specific and versatile biomolecular recognition-based 
self-assembly on a variety of inorganic materials such as metals, metal oxides, 
ceramics,32–36 as well as on polymeric materials.37–40 The biological nature of these short 
peptide sequences allows for the incorporation of additional functionalities, thereby 
providing a means for chimeric protein or peptide design.33,41 The combination of the 
complex functionalities presented in one chimeric peptidic molecule enables adaptable 
surface functionalization by facilitating the formation of biomimetic interfaces where 
bioactive domains can be displayed with the desired orientation while building upon the self-
assembly of the surface recognition domain. The self-organization of such biomolecular 
assemblies on surfaces of varying compositions and topographical complexities under 
physiological conditions make them highly desirable by eliminating the need for complex 
chemical reactions and harsh chemicals used in conventional chemical cross-linking 
systems.
Here we report the development of a nanotopographic cell culture platform composed of a 4 
× 4-island nanopatterned substrate engineered to have a biomimetic interface for screening 
hiPSC-CM structural development. The interface is achieved by using a chimeric peptide, 
which self-assembles onto nanopatterned substrates due to a polyurethane acrylate (PUA) 
binding domain, whereas displaying an integrin-binding domain (RGD) to facilitate 
consistent and physiologically relevant cell adhesion to the patterned surface. The chimeric 
peptide treated surfaces were shown to have comparable ability to promote cell adhesion on 
PUA substrates compared to a standard ECM protein coating (i.e., fibronectin). Additionally, 
when coupled with this chimeric cell adhesion peptide, a narrow range of nanogroove 
dimensions were found to enhance the organization and structural maturation of individual 
human induced pluripotent stem cell-derived cardiomyocytes. These results will be of 
significant value to researchers seeking to investigate cardiomyocyte development within 
more highly defined culture conditions for both clinical and basic science applications.
2. MATERIALS AND METHODS
2.1. Fabrication of PUA Nanogrid Array
Nanopatterned surfaces were comprised of a poly(urethane acrylate) (PUA)-based polymer 
(Norland Optical Adhesive; NOA 76, 6.7 MPa or 6.7 × 103 kPa) bound to glass substrates. 
All substrate fabrication was accomplished using UV-assisted capillary force lithography 
(CFL) methods described previously (Figure 1A).42 Prefabricated silicon masters (first 
generation master) were used as the starting step in the fabrication of nanopatterned 
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substrates. The first generation master had a 4 × 4 island pattern with 16 pattern dimensions 
(Figure 1 B). All 16 patterned area had a uniform depth of 500 nm. second generation 
substrates consisted of PUA 301 (Minuta Technology) with a modulus of 19.8 MPa 
patterned onto polyester terephthalate (PET) films. Briefly, PUA was drop-dispensed on to 
clean, first-generation silicon master surfaces without antistick coating (100% ethanol or 
xylene treated and dried under O2/N2 gas). A transparent PET film was then placed over the 
dispensed PUA. The silicon master, prepolymer, and PET were cured under a UV light (λ = 
365 nm) for 50 s. After curing, the PET film was carefully removed to leave PUA attached 
to the PET film with a negative of the silicon master nanopattern. These second-generation 
PUA/PET nanopattern masters were then cured under a UV light for at least 12 h.
Glass slides were cleaned for 20 min in 100% ethanol or xylene and dried under O2/N2 gas 
before being ozone treated for 10 min and coated with glass primer (Minuta Technology 
Co.) to increase adhesion of the NOA polymer to the surface. NOA polymer was drop 
dispensed on the pretreated glass slide and the nanopatterned PUA/PET second generation 
master was placed face down on the polymer/glass surface. The NOA/PUA/PET complex 
was UV cured for 15 s followed by peeling off the PUA/PET master from the NOA and 
glass surface. Flat NOA surfaces were made by drop-dispensing NOA onto clean glass 
coverslips and spin coated to produce thin NOA films on top of glass substrates. All NOA-
glass surfaces were then cured under a UV light for at least 12 h prior to use in experiments.
2.2. Polyurethane Acrylate Binding Peptide (PUABP) Library Screening and Binding 
Analysis
Biotinylated PUABP candidates were incubated on PUA substrates at 37 °C for at least 12 h, 
after which substrates were then washed extensively to leave the surface with tightly bound 
peptides (Figure S1). A streptavidin-Alexa fluorescent conjugate (ThermoFisher) was then 
added to determine both the surface coverage and degree of immobilization of the PUABP 
candidates on PUA. Fluorescence intensity was recorded at room temperature with a Safire 
fluorophotometer (Tecan) at 519 nm emission and 495 nm excitation wavelengths. The 
binding assays were carried out at least in triplicate and across 4 independent assays. The 
amino acid sequences and the physicochemical properties of the rational peptide library used 
in the study are shown in Table S1.
Analysis of surface coverage of PUABP1 and PUABP2 was accomplished using a method 
similar to that described above during the peptide screening of the PUABP library. 
Biotinylated PUABP1 and PUABP2 candidates were immobilized on PUA surfaces, and the 
peptide layer was visualized using streptavidin-Alexa fluorescent labeling and fluorescence 
microscopy (TE 300L, Nikon) using a FITC filter (exciter 460–500, dichroic 505, emitter 
510–560; Chroma Technology Co.). The fluorescence intensities on the surfaces were 
recorded on four random areas via METAMORPH (Universal Imaging) imaging software 
that were further analyzed and quantified using the ImageJ (National Institutes of Health) 
image processing and analysis software.
The peptide-PUA binding was further quantified by measuring the fluorescence intensities at 
several peptide concentrations. To determine the dissociation constant (KD) of both PUABP 
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peptides, we fitted the experimental fluorescence intensity values to the Langmuir 
adsorption model using a least-squares regression.
2.3. Synthesis and Characterization of the Polyurethane Acrylate Binding Peptide–Arg-Gly-
Asp (PUABP-RGD)
Chimeric PUA binding peptide 1 + RGD (PUABP1-RGD; molecular weight: 2155.4) and 
PUABP2 + RGD (PUABP2-RGD; molecular weight: 2011.3) were both produced through 
solid-state synthesis using a CSBioe 336s automated peptide synthesizer on Wang resin via 
Fmoc chemistry and HBTU activation. The crude PUABP-RGD peptides were purified by 
reverse phase high performance liquid chromatography. The correct sequence and purity of 
synthetic chimeric PUABP-RGD peptides were verified by mass spectroscopy using a 
MALDI-TOF mass spectrometer (Table S2 and Figure S2).
2.4. Differentiation of Human-Induced Pluripotent Stem Cells into Cardiomyocytes
Cardiomyocyte differentiation was accomplished using a previously established protocol.43 
Undifferentiated human IMR90-induced pluripotent stem cells, originally derived from fetal 
lung fibroblasts (James A. Thomson, University of Wisconsin-Madison), were expanded 
using mouse embryonic fibroblast-conditioned medium supplemented with 5 ng/mL basic 
fibroblast growth factor (R&D systems). Cardiomyocytes were obtained using a directed 
differentiation method that involved the serial application of activin A (R&D systems) and 
bone morphogenetic protein-4 (BMP4, R&D systems) under serum-free, monolayer culture 
conditions. At specific points in the early stages of differentiation, the cultures were also 
supplemented with the Wnt agonist CHIR 99021 (Tocris), followed by the Wnt antagonist 
Xav 939 (Tocris). After 7 days of in vitro culture, cells were fed every other day with serum-
free RPMI (Invitrogen) supplemented with B-27 supplement (Invitrogen) and L-glutamine 
(Life Technologies). Only cell preparations containing at least 80% cardiac troponin T-
positive cardiomyocytes (by flow cytometry) were used for the described experiments.
2.5. Cardiomyocyte Culture
Differentiated IMR90 cardiomyocytes were dispersed using 0.05% trypsin-EDTA (Gibco) 
and replated at a density of 15,000 cells/cm2 on experimental surfaces for single-cell 
analysis. Culture medium (RPMI + B27 + Insulin) was changed every other day throughout 
the experiment. Prior to cell seeding, substrates were coated with PUABP-RGD (100 μM) 
peptides or fibronectin (50 μg/cm2, BD Biosciences) and incubated overnight at 37 °C. All 
structural analyses were performed following 21 days on experimental substrates (∼40 days 
total culture period).
2.6. Immunostaining
Cells were fixed at the end of the 3-week culture period with 4% paraformaldehyde 
(Affymetrix). Cells were then rinsed twice with PBS and permeabilized with 0.1% Triton-
X-100 (Sigma) in PBS for 10 min. Permeabilized samples were blocked with 1% bovine 
serum albumin (BSA, Sigma) in PBS for 40–60 min at room temperature. A mouse primary 
antibody against α-actinin (Sigma) was then diluted 1:1000 in PBS supplemented with 5% 
BSA, and incubated for 1 h at room temperature. A secondary antibody (goat antimouse 
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Alexa Fluor-594, Life Technologies) was diluted in PBS supplemented with 5% BSA to 
match the dilution of primary antibody. In addition, conjugated Alexa Fluor 488-phalloidin 
(Life Technologies) was added to the secondary antibody solution to facilitate F-actin 
staining. Samples were incubated at 37 °C with the secondary antibody solution for 1 h. 
Finally, samples were washed with PBS, and mounted onto glass microscope slides with 
VectaShield (Vector). A DAPI counterstain was included with the mounting medium for 
visualizing nuclei. Stained cells were stored at 4 °C until analysis via confocal microscopy.
2.7. Morphological Analysis
At least 5 images were taken for each experimental condition to obtain sample sizes in the 
range of 60 to 90 cells per condition. ImageJ (NIH) software was then used to determine cell 
area, cell perimeter, sarcomere length, and major and minor axis lengths (to provide a 
measure of circularity). Custom written MATLAB code, which analyzed the orientation of 
phalloidin-stained F-actin fibers within the cell, was used to assess the alignment of actin 
fibers within cultured cells with respect to the direction of the pattern as detailed 
previously.43,44 Measurements for each condition were compiled, and the percentage of cells 
within 5° of the underlying pattern direction was computed.
2.8. Statistical Analysis
All statistical analysis was performed using Microsoft Excel and Prism (GraphPad 
Software). One-way analysis of variance (ANOVA) tests were performed to determine the 
statistical significance of observed differences in cell structure from cultures maintained on 
different dimension nanotopographies, with suitable post hoc analyses performed to 
determine which specific conditions were statistically different from each other. A one-way 
ANOVA was also used to compare the binding affinity of streptavidin-Alexa fluorescent 
conjugates to surfaces treated with PUABP1, PUABP2, and untreated controls. A two-way 
ANOVA with suitable post hoc test for multiple comparisons was used to compare the 
binding affinity of hiPSC-CMs to surfaces treated with PUABP1, PUABP2, and fibronectin 
controls across multiple nanopattern dimensions. In all experiments, a p value less than 0.05 
was considered statistically significant.
3. RESULTS
3.1. Fabrication of Nanogrid Cell Culture Substrates for High-Throughput Study of 
Nanotopography-Induced Sarcomeric Development in Cardiomyocytes
The PUA nanogrid cell culture array used in this study was fabricated using CFL (Figure 
1A), and was comprised of a 5 × 5 mm nanopattern square with varying topographic 
dimensions arranged in a 4 × 4 grid. All patterns consisted of a parallel array of nanoscale 
grooves and ridges with a 1:1 groove width:ridge width ratio (same geometry) and groove/
ridge widths of 350, 400, 450, 500, 600, 700, 750, 800, 900, 1000, 1200, 1250, 1500, 1600, 
1800, or 2000 nm (Figure 1B). PUA substrates without any topographic patterning were 
used as “flat” controls. These nanogrid arrays were fabricated on single glass coverslips, 25 
mm in diameter, thereby allowing for the high-throughput analysis of cardiomyocyte 
structural development due to topographical cues while reducing experimental variability 
with regards to cell and medium batches.
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3.2. Characterization of Chimeric Peptide Library Binding Affinities onto Nanopatterned 
Substrates
PUA-binding peptide domains were screened from a rationally selected set of 15 peptide 
candidates that were previously reported to bind to polymeric materials.37–40 In the 
screening assay, biotinylated PUABP candidates were allowed to self-assemble on 
nonpatterned PUA substrates where they interacted with streptavidin-Alexa conjugates to 
produce a fluorescent signal, and the intensity of this signal was quantified to determine the 
amount of peptide bound to the substrate (Figure 2A). From surface binding assays, five of 
the tested peptides produced a quantifiable fluorescence signal (n = 4, Figure 2B). The two 
peptides with the greatest binding signals were selected for further PUA binding 
characterization, and were designated PUABP1 and PUABP2.
The selected peptides displayed a uniform surface coverage across the PUA substrate as 
verified by fluorescence imaging, while controls (bare surface and SA-Alexa without 
PUABP-biotin treated samples) displayed no discernible fluorescence (Figure 2C). Both 
peptides produced significantly greater fluorescence levels than control substrates (p < 0.05), 
and the average fluorescence readings for PUABP2 treated samples were significantly 
higher than those recorded from PUABP1 treated samples (p < 0.05) (Figure 2D).
The dissociation constant values (KD) for the selected peptides were calculated using 
Langmuir adsorption isotherms using the surface coverage values generated from 
fluorescence intensities at different peptide concentrations (0.001–100 μM range). Peptides 
exhibited subnanomolar to micromolar binding affinities to PUA, with KD values of 2.97 
μM and 0.34 μM for PUABP1 and PUABP2, respectively (Figure 2E). Peptide saturation on 
PUA was obtained at 100 μM, and this peptide concentration was used in all subsequent 
biological experiments.
To engineer the biomimetic interface for cell adhesion assessment, we next designed the 
chimeric peptides to integrate PUA surface recognition and self-assembling functionalities 
with a cell-binding capacity. The selected PUABP peptides, PUABP1 and PUABP2, were 
linked to the integrin binding peptide RGD with a flexible SGGG peptide spacer region to 
ensure both functionalities remained preserved.45,46 The resulting chimeric conjugates were 
abbreviated as PUABP1-RGD and PUABP2-RGD (Table 2 and Figure S1).
3.3. Assessment of Cell Attachment on Chimeric Peptide Functionalized Nanopatterned 
Substrates
Human cardiomyocytes were differentiated from an established induced pluripotent stem 
cell line (IMR90) using previously published methods (Figure 3a).43,47 Differentiated cells 
were plated on nanogrid arrays coated with either PUABP1-RGD or PUABP2-RGD 
peptides. Fibronectin (50 μg/mL) treated surfaces were also examined as a control. After 24 
h in culture, attached cells were counted for each pattern design and each surface treatment 
tested (Figure 3b). There were no significant differences observed in cell attachment 
between pattern dimensions or fibronectin coating (p > 0.05). Although it was expected that 
the change in substrate topographic dimensions would elicit different cell responses over 
time, the initial attachment similarities suggests uniform cell dispersion across all 
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experimental conditions. This ensured that observed differences in cellular development and 
maturation at later time-points were not simply due to differences in initial cell attachment, 
but rather to fundamental differences in cellular responses to the underlying topographic 
signals. Given the uniformity in cell attachment for all surface treatments, and the higher 
biotin binding affinity results for PUABP2 over PUABP1, PUABP2-RGD surface treatments 
were employed for all subsequent analyses.
3.4. Effects of Nanotopographic Pattern Dimensions on Cardiomyocyte Morphology
We evaluated the structural development of hiPSC-derived cardiomyocytes cultured on 
PUABP2-RGD treated nanopatterned substrates for 3 weeks by analyzing their cell area, 
perimeter, circularity, and anisotropy. Analysis highlighted significant differences in cell 
area, an important structural indicator of hiPSC-CM maturation, between cultures 
maintained on different surface patterns (p < 0.0001). Cell area on 800 nm wide 
nanopatterns was significantly larger than the cell area recorded on all other surfaces except 
750 nm patterns. All pattern dimensions between 600 and 1200 nm promoted the 
development of significantly larger cell areas than was achieved on flat controls. Pattern 
dimensions below 600 nm or above 1200 nm, however, produced cells with areas not 
significantly different from flat surfaces (Figure 4a).
Cell perimeter is another structural cardiac development marker, providing an indication of 
nonpathological cellular hypertrophy.47,48 As was seen with the analysis of cell area, the 
capacity for intermediate nanopattern dimensions to promote increases in cultured cell 
perimeter was observed. Cell perimeters exhibited significant differences between different 
surface patterns and flat controls (p < 0.0001). Specifically, cell perimeters on nanopatterns 
between 600 and 900 nm were significantly greater than all other experimental conditions, 
but were not significantly different from each other (p > 0.05) (Figure 4b).
Given the considerable importance of structural anisotropy in cardiomyocytes in vivo,44 
circularity becomes a valuable analytical tool when determining structural development of 
hiPSC-CMs in vitro. The single adult cardiomyocyte typically exhibits a rectangular 
elongated cell body with myofibrils aligned in parallel and a length:width ratio of 7:1.49 
Immature cardiomyocytes, on the other hand, possess a much more rounded morphology 
with disorganized myofibril structures. Therefore, a measurement of cell elongation via 
circularity indices, where an index of 1 indicates a perfect circle and an index of 0 indicates 
a straight line, provides a further indication of hiPSC-CM structural maturity. Evaluation of 
the circularity index of single hiPSC-CMs on different nanotopographies showed that the 
circularity index was significantly reduced on all patterns compared to flat controls and 2000 
nm topographies (p < 0.0001). There were no significant differences between any other 
experimental groups (though those between 700 and 1000 tended to be lowest), indicating 
that all nanopattern designs, with the exception of 2000 nm ones, were equally capable of 
promoting the development of cellular anisotropy in this in vitro system (Figure 4c).
Cell orientation was also evaluated as a measure of the degree to which cells responded to 
the underlying patterns. It was expected that the ability of cultured hiPSC-CMs to penetrate 
into nanogrooves would strongly influence overall cell alignment. As expected, the highest 
percentage of cells falling within 5 degrees of the pattern direction was achieved on 800 nm 
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patterns (86.57% of all cells examined; n = 67). By comparison, just 25.93% of cells 
counted on 350 nm patterns (n = 81) fell within 5 degrees of the pattern direction. On 2000 
nm patterns, 41.79% of counted cells (n = 67) fell within 5 degrees of the pattern direction, 
providing an indication of the degree of alignment variance between the largest and smallest 
pattern dimensions. All patterned surfaces promoted greater alignment than flat controls, on 
which only 6.32% of counted cells (n = 95) fell within 5 degrees of the pattern direction on 
other surfaces (Figure 4d).
3.5. Effects on Nanotopographic Pattern Dimensions on Sarcomere Development
Finally, immunostained images of hiPSC-CMs were used to evaluate the sarcomere length 
within cells cultured on each pattern dimension (Figure 5a). Sarcomere length is directly 
related to force production from cell contractions,50,51 and can be correlated to the Frank-
Starling law on the nanoscale.52 It has been reported that adult cardiomyocytes have 
sarcomere lengths in the region of 1.8–2.0 μm, whereas immature human pluripotent stem 
cell-derived cardiomyocytes often have sarcomere lengths of approximately 1.5 μm.47,53–56
Under the described experimental conditions, we report a maximum sarcomere length in 
cells maintained on intermediate pattern dimensions (Figure 5b). There was a significant 
increase in the sarcomere length of cells maintained on topographies with feature 
dimensions between 750 and 1000 nm and cells grown on all other patterns (p < 0.0001). No 
significant differences in sarcomere length were observed between cells maintained on 750, 
800, 900, and 1000 nm patterns (p > 0.05). The sarcomere length of cells on 800 nm 
substrates was 1.85 μm (±0.056), which is a substantial increase in length compared to other 
studies on hiPSC-CMs of a similar age (1.65 ± 0.02).47 We posit that the presence of an 
underlying topographic pattern with optimal dimensions promoted the structural 
organization of the internal cytoskeleton, which led to improved myofibril organization and 
sarcomere length development, a hallmark of cardiomyocyte maturation.
4. DISCUSSION
Despite the tremendous potential offered by advances in stem cell technologies, a lack of 
understanding with regards to how to drive the biomimetic development of hiPSC-derived 
cardiomyocytes in vitro has so far limited their effectiveness in drug screening, disease 
modeling, and mechanistic studies. This has led to numerous efforts to develop an in vitro 
environment that more closely mimics the native environmental features of the myocardium 
to facilitate correct phenotypic development. However, the current ability to achieve mature 
cells remains limited due to the complexity involved in native microenvironment 
recapitulation. We developed a nanogrid array comprised of parallel grooves with 
dimensions ranging from 350 to 2000 nm arranged as a 4 × 4-grid configuration using 
CFL.42 To create a more biologically relevant culture platform, we designed this array to 
mimic the complex ECM structure of the myocardial basement membrane. The cardiac 
ECM is made up of collagen fiber networks that range in size from a few hundred 
nanometers to several micrometers,15,57 and analysis of the in vivo cardiac environment has 
indicated that the underlying ECM topography strongly influences the alignment and 
subsequent function of cardiac tissues. The CFL technique employed herein allows for the 
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simple and reproducible generation of nanoscale features with high fidelity across large 
platforms like the one used in this study, thus making it possible to screen 16 distinct 
nanopattern designs in a single well in order to evaluate optimal substrate conditions for 
promoting cellular structural development in vitro.
To produce a biomimetic interface which may provide biologically and physiologically 
relevant surface properties, we designed a chimeric peptide comprising of a cell adhesion 
domain to facilitate cell adhesion, and a surface recognition domain to provide PUA binding 
with a controllable surface distribution. In the chimeric peptide design, the highly conserved 
RGD integrin-binding sequence was used as the cell adhesion domain, while for the surface 
recognition domain, peptides that can selectively bind to PUA substrates were screened from 
a rationally designed subset of biocombinatorially selected peptides (PUABP) (Table S1). 
The collected cell adhesion data demonstrate that cell attachment to the chimeric peptide and 
control fibronectin treated substrates was comparable on all topographic surfaces examined. 
The fact that cell attachment on PUABP-RGD-coated substrates was comparable to 
fibronectin treated controls highlights the applicability of the biomimetic interface design as 
a suitable surface treatment method for cardiomyocyte culture. The establishment of a 
peptide-mediated surface coating that incorporates selective surface binding with the desired 
bioactivity may provide a benefit in promoting the formation of more robust cardiomyocyte 
monolayers in future studies. Furthermore, the potential to bind the PUABP motif to other 
antigens for recognition and binding of specific cells is a credible application for this 
technology in the near future. Comparable cell binding observed on PUABP-RGD and 
fibronectin treated substrates highlights that synthetically manufactured peptides are capable 
of functioning equally well as biopolymers in a cell culture setting. Given the high cost 
associated with isolation and purification of human fibronectin, PUABP-RGD represents a 
credible cost-effective alternative for large-scale industrial cell culture.
Morphological analysis of hiPSC-CMs cultured on PUABP2-RGD functionalized substrates 
for 21 days showed increased cell alignment, area, and sarcomere lengths in cells maintained 
on intermediate topographies, with a peak in structural maturation observed on 800 nm 
features. These data are in accordance with previous work performed using rodent cells, 
demonstrating that human cardiomyocytes are similarly capable of responding to exogenous 
structural cues to generate more biomimetic in vitro cardiac cultures.58 Furthermore, the 
results indicate that an ideal range for topography-induced cardiomyocyte development 
exists in the upper nanometer range. Ultrastructural analysis of the native myocardial ECM 
reveals aligned fibrils approximately 100 nm in diameter, with previous reports of collagen 
fibrils varying in diameter from 30 to 120 nm.59 Although both are in the nanometer range, 
comparison of in vitro and in vivo data suggests that larger topographies are required in vitro 
to promote cardiomyocyte maturation than cells would likely be exposed to in vivo. This 
disparity is likely attributable to the inherent differences in 3D and 2D cellular 
environments. In 3D, cardiac cells are surrounded and pressed on all sides by ECM fibers 
and other cells oriented uniaxially. As such, they would likely be more receptive to the 
mechanical cues that surround them on all sides. In 2D, cultured cells are less mature, and 
only influenced by topographical cues on a single plane. Consequently, it seems plausible 
that such cells would require significantly more pronounced structural cues to guide their 
uniaxial development and maturation. Additionally, it has been reported that the width of the 
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grooves on a topographically patterned substrate directly affects the ability of cultured cell 
bodies to penetrate the topography.15,60 The penetration level of a given cell influences the 
degree to which that cell will elongate and align with the underlying pattern, which in turn 
affects the degree to which the pattern is able to drive cellular development and maturation 
in vitro.16 As cells are less able to penetrate into smaller groove widths, the influence of the 
topography becomes less apparent on extremely narrow topographies. However, cells seeded 
onto much larger groove widths also encounter problems that inhibit their ability to induce 
structural maturation. As the widths become extremely large (micron scale), cells become 
isolated on top of ridges or within individual grooves, and the section of the cell that 
interacts with the underlying substrate is not able to respond to the substrate directional cues, 
as it only comes into contact with the surface of a ridge (which appears flat) or the bottom of 
a single groove. Therefore, our results suggest the existence of optimal groove-ridge 
dimensions that are wide enough to influence cellular orientation and maturation, but narrow 
enough to enable the cell to detect the underlying physical cues, thereby highlighting the 
differing ability of cultured cells to respond to varied nanotopographic cues.
A critical point for the future application of hiPSC-CMs is the drastically reduced cell 
circularity on nanopatterned cultures compared to flat controls observed at a 3-week time 
point. Lundy et al. reported a similar reduction in hiPSC-CM circularity on flat culture 
substrates following substantially protracted culture periods.47 Late stage (∼100 day) 
circularity measurements from this study were similar to those found in our analysis of cells 
on nanopatterned substrates after only 3 weeks (21 days postreplating, ∼ 40 days total 
culture time). From this comparison, it is clear that the presence of underlying ECM 
topography promotes improved structural maturity in cultured hiPSC-CMs at a far faster rate 
than is achievable on conventional flat culture surfaces. Such a result highlights the 
importance of nanotopographic surfaces for stem-cell-based cardiac bioengineering where 
mature phenotypes are desired with shorter lead times.
5. CONCLUSION
We have detailed the development of a platform in which different nanogroove widths can 
be used to examine structural maturation in human iPSC-derived cardiomyocytes in a high-
throughput manner. Using this system, we highlight that human cardiac cells respond to 
exogenous structural cues by orienting into a parallel array that more closely mimics the 
structure of the native mammalian myocardium. The developed platform incorporates a 
chimeric peptide, PUABP2-RGD, as an alternative to conventional biopolymers such as 
fibronectin for achieving a defined, cost-effective, and reproducible surface coating for 
promoting cardiomyocyte attachment. Future studies could focus on other similarly 
bioactive molecules (that activate signaling pathways such as Wnt) for application in the 
development of biomimetic interfaces for promoting cellular development and maturation in 
vitro.46 The collected results highlight the improved cellular development on surfaces that 
mimic the physical alignment of the native ECM. Previous studies have found that substrate 
elasticity that recapitulates what is observed in vivo are better suited to promoting 
cardiomyocyte structural and functional maturation.16,61,62 Given that, these results further 
highlight how accurate recreation of the myocardial niche is advantageous in promoting 
cellular development in vitro. This study will be of significant value to researchers seeking 
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to develop in vitro platforms capable of promoting hiPSC-CM maturation for drug 
screening, disease modeling, and cardiac developmental studies in the near future.
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Fabrication and arrangement of nanopatterned substrates on the nanogrid cell culture array. 
(A) Schematic illustration of UV-assisted capillary force lithography (CFL) process used to 
generate nanotopographically defined PUA-based cell culture substrates. (B) Diagram of 
nanogrid array designed for high-throughput structural maturation analyses of cultured cells. 
SEM images illustrate the surface dimensions of small (400 μm), medium (800 and 1200 
μm), and large (2000 μm) topographic features analyzed during this study.
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Characterization of chimeric adhesion peptide affinity to PUA substrates. (A) Schematic 
illustration of assay to determine degree of peptide affinity for PUA substrates, in which 
PUABP-biotin is incubated with SA-Alexa and the resulting fluorescence emission is 
measured. (B) PUA binding assay for rational peptide library, each peptide was conjugated 
to biotin prior to use in assay. No fluorescence was detected for peptides #6–15. n = 4. (C, 
D) PUABP surface coverage characterization at 100 μM. Fluorescence microscopy was used 
to determine surface binding density compared to a blank surface (negative control; NC) and 
surfaces treated with SA-Alexa without PUABP-biotin. Average fluorescence intensity was 
measured at multiple locations on each examined substrate (n ≥ 5). PUABP2-biotin 
displayed similar surface coverage compared to PUABP1-biotin, but a higher average 
fluorescent intensity. Scale bar: 10 μm. (E) Binding curve of PUABP1 and 2 with saturation 
occurring for both compounds at 100 μM.
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Directed cardiomyocyte differentiation from hiPSCs and comparative characterization of 
their adhesion to functionalized PUA substrates. (A) Representative schema of protocol for 
differentiating hiPSCs into cardiomyocytes. Prior to Day 0, undifferentiated IMR90 human 
iPSCs were cultured in mouse embryonic fibroblast-conditioned medium. At Day 0, 
undifferentiated cells were induced with activin-A, followed by BMP-4 between Days 1 and 
3. Between Days 3 and 5, the cells were treated with XAV939 (XAV), a tankyrase inhibitor. 
During the first week of differentiation, cells were maintained in RPMI medium with B27 
(without insulin). From Day 7 onward, insulin-containing B27 was used to supplement 
medium. Cells were maintained on Matrigel-coated surfaces until Day 21 before being 
harvested using trypsin and replated onto experimental surfaces. Medium was changed every 
other day throughout this time course. (B) Cell adhesion analysis of IMR90 cardiomyocytes 
24 h post replating on the nanogrid array coated with 100 μM of PUABP1-RGD or 
PUABP2-RGD. Statistical analysis yielded no significant differences in cell adhesion among 
pattern dimensions and ECM coating. p > 0.05, n = 20 (distinct areas) per condition.
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Quantitative analysis of cardiomyocyte morphology in response to different nanopatterned 
topographies. (A) Cell area analysis of IMR90 cardiomyocytes 3 weeks post replating 
pattern dimensions from 4 × 4-island platform coated with PUABP2-RGD (100 μM). *p < 
0.05. (B) Cell perimeter analysis of IMR90 hiPSC-cardiomyocytes 3 weeks post plating on 
different nanotopographic surfaces from 4 × 4-island platform coated with PUABP2-RGD 
(100 μM). Statistically significant increases in cell perimeter were observed in cells 
maintained on 600–900 nm groove widths when compared to all other patterned conditions 
and flat controls. *p < 0.05. (C) Cell circularity analysis of IMR90 cardiomyocytes 3 weeks 
post replating pattern dimensions from 4 × 4-island platform coated with PUABP2-RGD 
(100 μM). Cells on flat and 2000 nm patterned surfaces had significantly higher circularity 
indices than all other patterned conditions, indicating less anisotropic development in these 
conditions. *p < 0.05. (D) Cell alignment analysis of IMR90 cardiomyocytes 3 weeks post 
replating on pattern dimensions from 4 × 4-island platform coated with PUABP2-RGD (100 
μM). Alignment was determined by the percentage of cells whose major axis was within 5 
degrees of the pattern direction. Cells on 800 nm nanogroove width exhibited the highest 
degree of cell alignment compared to all other surface conditions. For all the analyses, n = 
60–95 cells per condition.
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Analysis of sarcomere development in hiPSC-cardiomyocytes cultured on nanotopographic 
substrates of different dimensions. (A) Confocal images of IMR90 cardiomyocytes with 
inset image fixed 3 weeks post replating on PUABP2-RGD (100 μM) coated nanogrid array. 
Red, α-actinin; green, f-actin; blue, nuclei. Scale bar: 20 μm. (B) Sarcomere length analysis 
of IMR90 cardiomyocytes 3 weeks post replating on 4 × 4-island platform coated with 100 
μM PUABP2-RGD. Statistically significant increases in sarcomere length were observed 
between cells on intermediate (750–1000 nm) groove widths. *p < 0.05.
Carson et al. Page 21
ACS Appl Mater Interfaces. Author manuscript; available in PMC 2017 November 11.
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
A
uthor M
anuscript
